Adverse reactions to vaccines practice parameter 2012 update - 27/06/12
Doi : 10.1016/j.jaci.2012.04.003
John M. Kelso, MD : Chief Editor, Matthew J. Greenhawt, MD, MBA : Chief Editor, James T. Li, MD, PhD : Chief Editor
Richard A. Nicklas, MD : Task Force Reviewer, David I. Bernstein, MD : Task Force Reviewer, Joann Blessing-Moore, MD : Task Force Reviewer, Linda Cox, MD : Task Force Reviewer, David Khan, MD : Task Force Reviewer, David M. Lang, MD : Task Force Reviewer, John Oppenheimer, MD : Task Force Reviewer, Jay M. Portnoy, MD : Task Force Reviewer, Christopher R. Randolph, MD : Task Force Reviewer, Diane E. Schuller, MD : Task Force Reviewer, Sheldon L. Spector, MD : Task Force Reviewer, Stephen A. Tilles, MD : Task Force Reviewer, Dana Wallace, MD : Task Force Reviewer
Key words : Vaccine, immunization, adverse reaction, allergy, influenza vaccine, egg allergy
Abbreviations used : AAAAI, AAP, ACAAI, CDC, DNR, DTaP, DTP, GBS, JTFPP, LAIV, MMR, Td, Tdap, TIV, VAERS
Plan
| Disclosure of potential conflict of interest: M. Greenhawt is on the Phadia/Thermo Fisher Scientific specialty advisory board and speakers’ bureau; is on the advisory boards for Nutricia and Sunovion; has received research support from the American College of Allergy, Asthma & Immunology (ACAAI), a private foundation, and from the National Institutes of Health (NIH)/Clinical and Translational Science Awards (CTSA); is a medical advisor for the Kids with Food Allergies Foundation; is on the American Academy of Allergy, Asthma & Immunology’s (AAAAI) Adverse Reactions to Foods Committee, Anaphylaxis Committee, and EGID Committee; and has received nonfinancial support from the Food Allergy & Anaphylaxis Network (FAAN). J. T. Li has stock shares in Abbott, Novartis, and Johnson & Johnson. J. M. Kelso declares that he has no relevant conflicts of interest. |
|
| Corresponding author: Joint Council of Allergy, Asthma & Immunology, 50 N Brockway St, #3-3, Palatine, IL 60067. E-mail: info@jcaai.org. |
© 2012
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 130 - N° 1
P. 25-43 - juillet 2012 Retour au numéro
Article précédent
- Statement regarding “The public health benefits of air pollution control”
- Dennis K. Ledford, A. Wesley Burks, Mark Ballow, Linda Cox, Robert A. Wood, Thomas B. Casale
- Does diversity of environmental microbial exposure matter for the occurrence of allergy and asthma?
- Dick Heederik, Erika von Mutius
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?